Prolacta Bioscience
PrivateLast Round
M&A
Dec 30, 2024
Total Funding Raised
$80.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Prolacta Bioscience operates in Healthcare & Life Sciences and is based in Duarte, California. Its latest recorded funding round was a Series E round in May 2018.
Prolacta Bioscience is a life sciences company that develops and manufactures human milk-based nutritional products for critically ill and premature infants in neonatal intensive care units.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prolacta Bioscience Comparables
Compare Prolacta Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LactaLogics | 78% | |
| Abbott Laboratories | 78% | |
| Medolac Laboratories | 76% |
For institutional investors. Book with your work email.
Prolacta Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Dec 30, 2024 | ||||
| Series E | May 14, 2018 | ||||
| Series E | Dec 6, 2016 | ||||
| Series D | Nov 3, 2011 | ||||
| Series C | May 23, 2007 | ||||
Series B | Oct 4, 2006 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prolacta Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DFJ Frontier | Series C |
| EW Healthcare Partners | M&A, Series E |
| Gideon Hixon Fund | Series C |
| Aisling Capital | Series E |
| Draper Associates | Series C |
| PhillipCapital Group | Series C |
| Arcturus Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 328, 101% of current headcount.
- Jun 27, 2026
Product used by over 100,000 premature infants globally.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 2, 2026
Since introducing Prolact+ H2MF(R) in 2006, Prolacta Bioscience provides a 100% human breastmilk-based fortifier that supports feeding and outcomes for premature infants weighing 2.75 pounds or less in neonatal intensive care units.
For institutional investors. Book with your work email.
Prolacta Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prolacta Bioscience's valuation, stock price, and market status.
Is Prolacta Bioscience a public or private company?
Prolacta Bioscience is a private company.
What is the current stock price of Prolacta Bioscience?
Prolacta Bioscience is a private company, so its shares have no public market price. Caplight tracks Prolacta Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prolacta Bioscience worth (valuation)?
Valuation information for Prolacta Bioscience is not publicly available.
Can I buy Prolacta Bioscience stock?
Prolacta Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prolacta Bioscience's last funding round?
Prolacta Bioscience's most recent funding round was M&A on December 30, 2024.
Who are the main investors in Prolacta Bioscience?
Key investors in Prolacta Bioscience include EW Healthcare Partners, Alta Partners.
Will Prolacta Bioscience IPO soon?
No public IPO plans have been announced for Prolacta Bioscience.
How can I track Prolacta Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Prolacta Bioscience's shares on secondary markets.